Breathlin SR

Generic Name: Theophylline 200 mg
Dosage Form: Tablet
TG Name: Respiratory

Breathlin^® SR is structurally classified as a methylxanthine. It occurs as a white, odorless, crystalline powder with a bitter taste. Breathlin^® SR Tablets in a controlled-release system allows a 24-hour dosing interval for appropriate patients. Breathlin^® SR is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.

Breathlin^® SR (Theophylline^® SR anhydrous tablet) is contraindicated in patients with a history of hypersensitivity to Breathlin^® SR or other components in the product. Breathlin^® SR should be administered carefully to children under 6 months of age.

• Cost effective than other therapies
• Unique SR formulation ensures less side-effects
• Once daily anti-asthmatic ensures patient compliance